| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate |
2003-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a8a1cb36c35065d98f072e3cf942055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81b3904f46c9fbebfe9ae2e065998be6 |
| publicationDate |
2003-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003153743-A1 |
| titleOfInvention |
Processes for the synthesis of oligomeric compounds |
| abstract |
Methods for the preparation of oligonucleotides having bioreversible phosphate blocking groups are disclosed. The oligonucleotides are prepared utilizing amidite type chemistry wherein the bioreversible phosphorus protecting group is formed as an integral part of the amidite reagent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014031575-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021249825-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015529073-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9950001-B2 |
| priorityDate |
1998-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |